Roberto Souza, Beatriz Divino, Helena N. M. Rocha, Jocemir R. Lugon, Natalia G. Rocha, Antonio C. L. Nobrega, Eliza Prodel
{"title":"从COVID-19男性和女性恢复后,心脏压力反射得以保留","authors":"Roberto Souza, Beatriz Divino, Helena N. M. Rocha, Jocemir R. Lugon, Natalia G. Rocha, Antonio C. L. Nobrega, Eliza Prodel","doi":"10.1111/jch.70006","DOIUrl":null,"url":null,"abstract":"<p>We sought to investigate whether mild COVID-19 impairs cardiac baroreflex sensitivity (cBRS), using the modified Oxford protocol, in young healthy men and women 12–14 weeks after recovering from the infection. Participants were distributed into two groups: Non-COVID-19 group (NCG: men <i>n</i> = 6 [30 ± 3years; 26 ± 1 kg/m<sup>2</sup>] and women <i>n</i> = 5 [25 ± 1 years; 25 ± 1 kg/m<sup>2</sup>]) and recovered from COVID-19 group (RCG: men <i>n</i> = 6 [29 ± 3 years; 25 ± 1 kg/m<sup>2</sup>] and women <i>n</i> = 10 [32 ± 4 years; 22 ± 1 kg/m<sup>2</sup>]), the RCG tested positive (RT-PCR) 12 to 14 weeks before the protocol. Beat-to-beat finger blood pressure (BP) and heart rate (HR) were measured during a bolus of sodium nitroprusside (SNP) and phenylephrine (PHE), in a control condition and during cold pressor test (CPT) and moderate dynamic handgrip exercise (GRIP). Resting systolic BP was higher in the RCG (135 ± 14 mmHg vs. 122 ± 12 mmHg, <i>p</i> = 0.01). Both CPT and GRIP maneuvers increased HR and BP; the bolus of SNP diminished BP and evoked a reflex-mediated increase in HR; PHE increased BP, resulting in a reflex-mediated decrease in HR. Of note, cBRS for decrease or increase of BP did not differ between groups under the studied conditions: control (SNP, <i>p</i> = 0.39; PHE, <i>p</i> = 0.50); CPT (SNP, <i>p</i> = 0.09; PHE: <i>p</i> = 0.82); and GRIP (SNP, <i>p</i> = 0.35; PHE, <i>p</i> = 0.53). In conclusion, mild COVID-19 did not seem to impair cBRS in healthy young men and women 12–14 weeks after recovering from the infection.</p>","PeriodicalId":50237,"journal":{"name":"Journal of Clinical Hypertension","volume":"27 2","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2025-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jch.70006","citationCount":"0","resultStr":"{\"title\":\"Cardiac Baroreflex Is Preserved After the Recovery From COVID-19 Men and Women\",\"authors\":\"Roberto Souza, Beatriz Divino, Helena N. M. Rocha, Jocemir R. Lugon, Natalia G. Rocha, Antonio C. L. Nobrega, Eliza Prodel\",\"doi\":\"10.1111/jch.70006\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>We sought to investigate whether mild COVID-19 impairs cardiac baroreflex sensitivity (cBRS), using the modified Oxford protocol, in young healthy men and women 12–14 weeks after recovering from the infection. Participants were distributed into two groups: Non-COVID-19 group (NCG: men <i>n</i> = 6 [30 ± 3years; 26 ± 1 kg/m<sup>2</sup>] and women <i>n</i> = 5 [25 ± 1 years; 25 ± 1 kg/m<sup>2</sup>]) and recovered from COVID-19 group (RCG: men <i>n</i> = 6 [29 ± 3 years; 25 ± 1 kg/m<sup>2</sup>] and women <i>n</i> = 10 [32 ± 4 years; 22 ± 1 kg/m<sup>2</sup>]), the RCG tested positive (RT-PCR) 12 to 14 weeks before the protocol. Beat-to-beat finger blood pressure (BP) and heart rate (HR) were measured during a bolus of sodium nitroprusside (SNP) and phenylephrine (PHE), in a control condition and during cold pressor test (CPT) and moderate dynamic handgrip exercise (GRIP). Resting systolic BP was higher in the RCG (135 ± 14 mmHg vs. 122 ± 12 mmHg, <i>p</i> = 0.01). Both CPT and GRIP maneuvers increased HR and BP; the bolus of SNP diminished BP and evoked a reflex-mediated increase in HR; PHE increased BP, resulting in a reflex-mediated decrease in HR. Of note, cBRS for decrease or increase of BP did not differ between groups under the studied conditions: control (SNP, <i>p</i> = 0.39; PHE, <i>p</i> = 0.50); CPT (SNP, <i>p</i> = 0.09; PHE: <i>p</i> = 0.82); and GRIP (SNP, <i>p</i> = 0.35; PHE, <i>p</i> = 0.53). In conclusion, mild COVID-19 did not seem to impair cBRS in healthy young men and women 12–14 weeks after recovering from the infection.</p>\",\"PeriodicalId\":50237,\"journal\":{\"name\":\"Journal of Clinical Hypertension\",\"volume\":\"27 2\",\"pages\":\"\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2025-02-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jch.70006\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Clinical Hypertension\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/jch.70006\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PERIPHERAL VASCULAR DISEASE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Hypertension","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/jch.70006","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0
摘要
我们试图在感染恢复后12-14周的年轻健康男性和女性中,使用改进的牛津方案,调查轻度COVID-19是否会损害心脏压力反射敏感性(cBRS)。参与者分为两组:非covid -19组(NCG:男性n = 6[30±3岁;26±1 kg/m2],女性n = 5[25±1岁];25±1 kg/m2]),并从COVID-19组中恢复(RCG:男性n = 6[29±3年;25±1 kg/m2],女性n = 10[32±4岁];22±1 kg/m2]),治疗前12 ~ 14周RCG检测呈阳性(RT-PCR)。在对照条件下、冷压试验(CPT)和适度动态握力运动(GRIP)期间,分别测量硝普钠(SNP)和苯肾上腺素(PHE)注射期间手指搏动血压(BP)和心率(HR)。RCG组静息收缩压较高(135±14 mmHg vs 122±12 mmHg, p = 0.01)。CPT和GRIP动作均增加心率和血压;SNP的加入降低了血压并引起了反射性的HR升高;PHE增加血压,导致反射介导的HR降低。值得注意的是,在研究条件下,各组之间血压升高或降低的cBRS没有差异:对照组(SNP, p = 0.39;PHE, p = 0.50);CPT (SNP, p = 0.09;PHE: p = 0.82);GRIP (SNP, p = 0.35;PHE, p = 0.53)。总之,在感染康复后12-14周的健康年轻男性和女性中,轻度COVID-19似乎没有损害cBRS。
Cardiac Baroreflex Is Preserved After the Recovery From COVID-19 Men and Women
We sought to investigate whether mild COVID-19 impairs cardiac baroreflex sensitivity (cBRS), using the modified Oxford protocol, in young healthy men and women 12–14 weeks after recovering from the infection. Participants were distributed into two groups: Non-COVID-19 group (NCG: men n = 6 [30 ± 3years; 26 ± 1 kg/m2] and women n = 5 [25 ± 1 years; 25 ± 1 kg/m2]) and recovered from COVID-19 group (RCG: men n = 6 [29 ± 3 years; 25 ± 1 kg/m2] and women n = 10 [32 ± 4 years; 22 ± 1 kg/m2]), the RCG tested positive (RT-PCR) 12 to 14 weeks before the protocol. Beat-to-beat finger blood pressure (BP) and heart rate (HR) were measured during a bolus of sodium nitroprusside (SNP) and phenylephrine (PHE), in a control condition and during cold pressor test (CPT) and moderate dynamic handgrip exercise (GRIP). Resting systolic BP was higher in the RCG (135 ± 14 mmHg vs. 122 ± 12 mmHg, p = 0.01). Both CPT and GRIP maneuvers increased HR and BP; the bolus of SNP diminished BP and evoked a reflex-mediated increase in HR; PHE increased BP, resulting in a reflex-mediated decrease in HR. Of note, cBRS for decrease or increase of BP did not differ between groups under the studied conditions: control (SNP, p = 0.39; PHE, p = 0.50); CPT (SNP, p = 0.09; PHE: p = 0.82); and GRIP (SNP, p = 0.35; PHE, p = 0.53). In conclusion, mild COVID-19 did not seem to impair cBRS in healthy young men and women 12–14 weeks after recovering from the infection.
期刊介绍:
The Journal of Clinical Hypertension is a peer-reviewed, monthly publication that serves internists, cardiologists, nephrologists, endocrinologists, hypertension specialists, primary care practitioners, pharmacists and all professionals interested in hypertension by providing objective, up-to-date information and practical recommendations on the full range of clinical aspects of hypertension. Commentaries and columns by experts in the field provide further insights into our original research articles as well as on major articles published elsewhere. Major guidelines for the management of hypertension are also an important feature of the Journal. Through its partnership with the World Hypertension League, JCH will include a new focus on hypertension and public health, including major policy issues, that features research and reviews related to disease characteristics and management at the population level.